158 related articles for article (PubMed ID: 21227895)
1. Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques.
Ravić-Nikolić A; Radosavljević G; Jovanović I; Zdravković N; Mitrović S; Pavlović S; Arsenijević N
Eur J Dermatol; 2011; 21(1):53-7. PubMed ID: 21227895
[TBL] [Abstract][Full Text] [Related]
2. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23.
Piskin G; Tursen U; Sylva-Steenland RM; Bos JD; Teunissen MB
Exp Dermatol; 2004 Dec; 13(12):764-72. PubMed ID: 15560760
[TBL] [Abstract][Full Text] [Related]
3. Influence of systemic photochemotherapy on regulatory T cells and selected cytokine production in psoriatic patients: a pilot study.
Rotsztejn H; Zalewska A; Trznadel-Budźko E; Lewkowicz P; Banasik M; Tchórzewski H; Głowacka E
Med Sci Monit; 2005 Dec; 11(12):CR594-8. PubMed ID: 16319792
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
Oxholm A; Oxholm P; Staberg B; Bendtzen K
Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
[TBL] [Abstract][Full Text] [Related]
5. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-12 in the pathogenesis of psoriasis.
Shaker OG; Moustafa W; Essmat S; Abdel-Halim M; El-Komy M
Clin Biochem; 2006 Feb; 39(2):119-25. PubMed ID: 16386240
[TBL] [Abstract][Full Text] [Related]
7. T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
Arch Dermatol Res; 2004 May; 295(12):509-16. PubMed ID: 15024577
[TBL] [Abstract][Full Text] [Related]
8. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.
Companjen A; van der Wel L; van der Fits L; Laman J; Prens E
Eur Cytokine Netw; 2004; 15(3):210-6. PubMed ID: 15542445
[TBL] [Abstract][Full Text] [Related]
9. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.
Toichi E; Torres G; McCormick TS; Chang T; Mascelli MA; Kauffman CL; Aria N; Gottlieb AB; Everitt DE; Frederick B; Pendley CE; Cooper KD
J Immunol; 2006 Oct; 177(7):4917-26. PubMed ID: 16982934
[TBL] [Abstract][Full Text] [Related]
10. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris.
Zhu K; Ye J; Wu M; Cheng H
Arch Dermatol Res; 2010 Sep; 302(7):517-23. PubMed ID: 20333526
[TBL] [Abstract][Full Text] [Related]
11. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
13. Effects of PUVA therapy on skin surface lipids: skin surface lipid peroxidation in psoriasis vulgaris and its biological significance.
Hayakawa K; Matsuo I
Tokai J Exp Clin Med; 1986 Nov; 11(5):317-22. PubMed ID: 3672560
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
15. Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy.
Salgo R; Thaçi D; Boehncke S; Diehl S; Hofmann M; Boehncke WH
Exp Dermatol; 2011 Feb; 20(2):130-3. PubMed ID: 21255092
[TBL] [Abstract][Full Text] [Related]
16. PUVA irradiation restores altered binding patterns of lectins in psoriatic epidermis.
Danno K; Yoneda K; Horio T
Arch Dermatol; 1986 Jul; 122(7):772-8. PubMed ID: 2425750
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 in psoriatic plaques treated with PUVA and methotrexate.
El-Komy M; Amin I; Zidan A; Kadry D; Zeid OA; Shaker O
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1288-94. PubMed ID: 21241374
[TBL] [Abstract][Full Text] [Related]
18. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
Wei L; Debets R; Hegmans JJ; Benner R; Prens EP
J Pathol; 1999 Feb; 187(3):358-64. PubMed ID: 10398092
[TBL] [Abstract][Full Text] [Related]
19. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
Oxholm A
APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.
Rácz E; de Leeuw J; Baerveldt EM; Kant M; Neumann HA; van der Fits L; Prens EP
Lasers Surg Med; 2010 Mar; 42(3):201-10. PubMed ID: 20333742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
